lobbying_activities: 3490129

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3490129	2d72653d-4d3e-4a2d-86bc-146f91d8c1e6	Q4	DLA PIPER LLP (US)	76855	REGENXBIO INC.	2025	fourth_quarter	MED	Issues related to rare disease.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2026-01-16T15:11:24-05:00